Top Markets
#1 0G 0G +43.07%
#2 Merlin's Seal BTC Merlin's Seal BTC +42.87%
#3 Useless Coin Useless Coin +29.81%
#4 SAFEcoin SAFEcoin +28.61%
#5 StonkBroker StonkBroker +28.19%
#6 Pons Pons +24.78%
#7 Zora Zora +21.88%
#8 Dogs Dogs +20.90%
#9 ICON ICON +20.51%
#10 Dash Dash +18.26%
Coin of the day
0G 0G
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Beijing Leadman Biochemistry Co.,Ltd. Beijing Leadman Biochemistry Co.,Ltd.

Beijing Leadman Biochemistry Co.,Ltd.

300289
Classement en actions #13635
Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's... Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.
Prix de l'action
$0.87093245
Capitalisation boursière
$473.80M
Changement (1 jour)
-1.48%
Changement (1 an)
-24.54%
Pays
CN
Échange Beijing Leadman Biochemistry Co.,Ltd. (300289)

Catégorie

Healthcare
Revenus pour Beijing Leadman Biochemistry Co.,Ltd. (300289)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de Beijing Leadman Biochemistry Co.,Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Beijing Leadman Biochemistry Co.,Ltd. de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US